We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Quantitative Ultrasound Parameters Offer New Tool for Diagnosing Lung Disease

By MedImaging International staff writers
Posted on 14 Aug 2024
Print article
Image: Lung quantitative ultrasound can be used to stage and monitor interstitial lung diseases (Photo courtesy of CDC)
Image: Lung quantitative ultrasound can be used to stage and monitor interstitial lung diseases (Photo courtesy of CDC)

Chronic interstitial lung diseases (ILDs) require regular point-of-care monitoring due to their persistent nature. Traditional X-ray methods are limited by lower resolution and ionizing radiation exposure. Chest CT scans, while detailed, are costly and also involve significant radiation exposure. Conventional ultrasound techniques can identify severe lung damage through the presence of vertical artifacts known as B-lines, but this data is qualitative and highly dependent on the operator and the ultrasound system used. Now, researchers have introduced innovative ultrasound-based biomarkers for a more precise assessment of ILD severity.

Researchers from North Carolina State University (Raleigh, NC, USA) have defined a set of ultrasound parameters that quantitatively evaluate various physical lung characteristics. These parameters have proven effective in both diagnosing and gauging the severity of lung diseases within an animal model. Diseases manifest in the lungs in diverse ways, altering aspects like the microstructure of the lung, tissue elasticity, and the type and volume of fluid present. Each alteration can be quantitatively measured using ultrasound. In their study published in Scientific Reports, the researchers aimed to identify specific parameters for these lung characteristics and to determine which parameters correlate with different lung diseases.

Initially, the team established parameters for a broad range of lung characteristics, such as alveolar density or fluid volume. They also adapted existing ultrasound parameters previously used for other organs to suit lung tissue assessment, culminating in a total of 60 different parameters. These were then applied to measure lung conditions in rats, which were either healthy or exhibited varying stages of fibrosis or edema—fibrosis being lung tissue scarring and edema referring to fluid accumulation. Statistical analysis helped identify which parameter combinations were linked to particular health conditions and were sensitive enough to indicate the severity of these conditions. They discovered that only five parameters were necessary to effectively assess both fibrosis and edema—three for fibrosis and two for edema.

The sensitivity of this new diagnostic tool was further validated through the treatment of fibrosis in rats; as the fibrotic rats received treatment, the tool accurately tracked improvements in their lung condition. The researchers have developed specialized data processing software that integrates with existing ultrasound machines, calculating the values for each parameter and determining biomarker scores for both edema and fibrosis. Future steps include computational simulations, in vitro tests, and animal model trials to confirm the efficacy of this method through thicker chest walls. If successful, the team plans to pursue clinical trials. The establishment of as many as 60 distinct parameters also creates the potential for this technique to be used for identifying diagnostic biomarkers for various other lung ailments.

“One of the challenges with many diagnostic tools is that there is often a trade-off between sensitivity and specificity,” said Marie Muller, co-senior author of a paper on the work and an associate professor of mechanical and aerospace engineering at North Carolina State University. “A highly sensitive test may virtually guarantee that you detect a problem, but it also usually means that there can be a lot of false positives. On the other hand, a highly specific test will almost never give you a false positive, but it may also miss quite a few health problems it is supposed to detect, or not be able to assess the severity of a specific disease. We’re excited about this new diagnostic tool because it is both highly sensitive and highly specific. And we’re able to have that combination of specificity and sensitivity because we are measuring multiple parameters.”

Related Links:
North Carolina State University

Computed Tomography System
Aquilion ONE / INSIGHT Edition
Ultrasound Imaging System
P12 Elite
New
Specimen Radiography System
Trident HD
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.